SLC2A1 and pancreatic ductal adenocarcinoma: IGF2BP2, as an N6- methyladenosine (m6A) reader, has been reported to be able to directly bind to and stabilize GLUT1 mRNA in pancreatic ductal adenocarcinoma and CRC [18].